Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-12-03

Clinical Trial Update: Use of Hyoscyamine Versus Tamsulosin for Management of Ureteral Stent Irritation [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing hyoscyamine to tamsulosin for ureteral stent irritation was terminated, and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hyoscyamine (hyoscyamine)
  • Tamsulosin (tamsulosin)

Snippet

Sponsor: University of Kansas Medical Center | Conditions: Lower Urinary Tract Symptoms | Phase 4 | Status: TERMINATED | Results posted: 2024-12-03